Empagliflozin vs Nivolumab

## Empagliflozin vs Nivolumab: Overview

This comparison examines the pharmacological differences between **Empagliflozin** and **Nivolumab**.

## Mechanism of Action

**Empagliflozin**: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

## Pharmacokinetics

**Half-life**: Empagliflozin — 12.4 hours; Nivolumab — 27 days.

## Chemical Properties

**Molecular Formula**: Empagliflozin — C23H27ClO7; Nivolumab — N/A.

**Molecular Weight**: Empagliflozin — 450.9100 g/mol; Nivolumab — N/A.

**Type**: Empagliflozin — Small molecule; Nivolumab — Antibody.